◆ NeutralERAS
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS
GlobeNewswire Inc.·
Rosen Law Firm is soliciting investors who purchased Erasca, Inc. (NASDAQ: ERAS) stock between January 14, 2025 and April 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. The lead plaintiff deadline is August 10, 2026.
Read Full Article at GlobeNewswire Inc. →